Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands - ...
The agreement also ends the Sacklers’ control of Purdue Pharma and prohibits them from selling opioids in the United States.
Proponents of the plan to equip paramedics with buprenorphine call it the "missing link" in the bridge to recovery for many ...
The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...
Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...
Since the opioid epidemic was declared an emergency in 2017, it has claimed more than 450,000 lives, but local drug and alcohol specialists are working to fight the crisis daily. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback